Evaluation of HER2 Status by Quantitative RT-PCR with Internal Specimen Quality Controls in Breast Cancer

被引:0
|
作者
Lin, Y. [1 ]
Yu, R. [2 ]
Hsu, W. [1 ]
Liu, Y. [3 ]
Chiu, K. [2 ]
Yeh, Y. [1 ]
机构
[1] Gen Biol Corp, Hsinchu, Taiwan
[2] Genet Dev Corp, Lake Bluff, IL USA
[3] Curiemed Corp, Hsinchu, Taiwan
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
S21
引用
收藏
页码:1003 / 1003
页数:1
相关论文
共 50 条
  • [21] Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients
    Otsuji, K.
    Sasaki, T.
    Tanaka, A.
    Kunita, A.
    Ikemura, M.
    Matsusaka, K.
    Tada, K.
    Fukayama, M.
    Seto, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients
    Kazutaka Otsuji
    Takeshi Sasaki
    Atsushi Tanaka
    Akiko Kunita
    Masako Ikemura
    Keisuke Matsusaka
    Keiichiro Tada
    Masashi Fukayama
    Yasuyuki Seto
    Breast Cancer Research and Treatment, 2017, 162 : 11 - 18
  • [23] A seminested RT-PCR assay for HER2/neu: Initial validation of a new method for the detection of disseminated breast cancer cells
    Wasserman, L
    Dreilinger, A
    Easter, D
    Wallace, A
    MOLECULAR DIAGNOSIS, 1999, 4 (01): : 21 - 28
  • [24] HER2 Amplification, Polysomy Status and Breast Cancer Survival in a Large Kaiser Permanente Case-Control Study: Assessment of HER2 by Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Fluorescence In Situ Hybridization (FISH)
    Baehner, F. L.
    Achacoso, N.
    Maddala, T.
    Alexander, C.
    Shak, S.
    Quesenberry, C. P.
    Habel, L. A.
    CANCER RESEARCH, 2009, 69 (24) : 824S - 824S
  • [25] Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR
    Koudelakova, Vladimira
    Berkovcova, Jitka
    Trojanec, Radek
    Vrbkova, Jana
    Radova, Lenka
    Ehrmann, Jiri
    Kolar, Zdenek
    Melichar, Bohuslav
    Hajduch, Marian
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (04): : 446 - 455
  • [26] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [27] HER2 status in bilateral breast cancer
    Crowe, Joseph P.
    Patrick, Rebecca J.
    Rybicki, Lisa A.
    Budd, G. Thomas
    Escobar, Pedro F.
    Tubbs, Raymond R.
    Hicks, David G.
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2006, 51 (05) : 219 - 223
  • [28] Assessment of HER2 status in breast cancer
    Penault-Llorca, F
    Cayre, A
    BULLETIN DU CANCER, 2004, 91 : S211 - S215
  • [29] Dual Contribution of Quantitative Image Analysis for the Evaluation of HER2 IHC Staining Quality, and Interpretation of HER2 Overexpression and HER2-Low Status in Breast Carcinoma
    Cossutta, Melissande
    Truumees, Birgit
    Papine, Alexandre
    Kristoffersen, Heidi
    Tatarinova, Ekaterina
    Homsy, Charles
    Nielsen, Soren
    Soussaline, Francoise
    LABORATORY INVESTIGATION, 2024, 104 (03) : S139 - S140
  • [30] HER2 testing in breast cancer by quantitative PCR: technical and clinical considerations.
    Yu, Rong
    Chen, Wen-Chung
    Chiu, Kung Y.
    Lu, Sunny
    Liu, Yuan-Chil
    Ko, Hsiao-Yun
    Wu, Han-Chieh
    Hsieh, Wen-Chaun
    Lee, Zi-jia
    Zhang, Peter
    Shi, Lili
    Liu, Ming
    Chang, Kung-Chao
    Su, Ih-Jen
    Su, Peggy
    Yeh, Yu-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)